Treatment of Chronic Tonsillitis with β-Hemolytic Streptococcal Infection in Penicillin-Allergic Patients (McIsaac Score ≥ 3, Age 15+)
This scenario applies to patients aged 15 and older with chronic tonsillitis and a highly suspected or confirmed β-hemolytic streptococcal infection — group A, C, or G — scoring at least 3 on the McIsaac scale, where penicillin-based therapy cannot be used due to allergy or incompatibility.
Clinical Scenario
Penicillin allergy / incompatibility
- β-hemolytic streptococcal infection — group A, C, or G — highly suspected or confirmed
- McIsaac score of at least 3
- Age 15 years and older
- Penicillin allergy or incompatibility present
Treatment Approach
Because penicillin is contraindicated in this population, antibiotic therapy relies on specific oral alternatives suited to the allergy context. One such alternative includes a macrolide antibiotic; additional options exist depending on the allergy type. The complete selection criteria, alternatives, and clinical guidance are contained in the full structured protocol.
Clinical Goal
With appropriate antibiotic therapy, patients — particularly adolescents and adults — are typically free of symptoms within 48 hours.
References
DOI: 10.1007/s00405-015-3872-6
- Antibiotic therapy is indicated only in case of a highly suspected or proven b-hemolytic streptococci infection (of group A, C, or G).
- In case of allergy/incompatibility:
- Age 15 years and older:
- Erythromycin-estolate (3 × 500 mg/day for 5 days), or 1st generation cephalosporin (e.g. cefadroxil 2 × 1000 mg/day for 5 days)
- Another alternative is clindamycin (20 mg/kg body weight/day in three single doses).
- In cases of allergies (acute type) against beta-lactam antibiotics, cephalosporins should not be applied because of frequent cross reactions.
- With adequate therapy, most of the patients, especially adolescents and adults, are free of symptoms within 48 h.
View source ↗